Millrace Asset Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-15,690
| Closed | -$933K | – | 84 |
|
2020
Q3 | $933K | Sell |
15,690
-8,762
| -36% | -$521K | 0.75% | 64 |
|
2020
Q2 | $1.71M | Buy |
+24,452
| New | +$1.71M | 1.74% | 20 |
|
2019
Q3 | – | Sell |
-21,915
| Closed | -$1.56M | – | 70 |
|
2019
Q2 | $1.56M | Sell |
21,915
-6,939
| -24% | -$494K | 1.61% | 25 |
|
2019
Q1 | $2.26M | Buy |
+28,854
| New | +$2.26M | 1.91% | 19 |
|